Latest

Alzheimer’s disease

·July 24, 2024·9 min read

Neural Vulnerabilities and Resilience in Alzheimer’s Explored

Researchers uncover how specific brain cells and circuits become vulnerable in Alzheimer's disease and identify factors that may promote resilience to cognitive decline. Analyzing gene expression in over 1.3 million cells across multiple brain regions, the study highlights the role of Reelin in neuron protection and choline metabolism in astrocytes for cognitive resilience. These findings pave the way for potential therapeutic targets to sustain cognition and memory amid Alzheimer’s pathology.

Featured Neurology Neuroscience Psychology

·July 24, 2024·3 min read

Anxiety Raises Dementia Risk

A new study reveals that chronic and new anxiety are linked to a higher risk of dementia, while resolved anxiety shows no such association. Following 2,132 Australian individuals for 10 years, researchers found that chronic and new anxiety increased dementia risk by 2.8 and 3.2 times, respectively. Those whose anxiety began before age 70 faced even greater risks. The findings suggest that addressing anxiety could help prevent dementia.

Featured Neurology Neuroscience

·July 17, 2024·6 min read

New Type of Age-Related Memory Loss Identified

Researchers established new criteria for Limbic-predominant Amnestic Neurodegenerative Syndrome (LANS), a memory-loss condition often mistaken for Alzheimer's disease. Unlike Alzheimer’s, LANS progresses more slowly and has a better prognosis. The criteria help doctors diagnose LANS in living patients using brain scans and biomarkers. This advancement aids in better management and tailored treatments for memory loss.

Featured Neurology Neuroscience

·July 13, 2024·7 min read

AI Predicts Alzheimer’s Progression

A new AI tool predicts Alzheimer's progression with 82% accuracy using cognitive tests and MRI scans, outperforming current methods. This tool could reduce the need for costly tests and improve early intervention. Alzheimer's disease is the main cause of dementia, affecting over 55 million people worldwide.

Featured Neurology Neuroscience

·July 11, 2024·4 min read

Study Reveals Structure of Alzheimer’s Molecules in Human Brain

In a groundbreaking study, scientists have determined the structure of molecules within a human brain affected by Alzheimer’s disease. Using cryo-electron tomography and fluorescence microscopy, researchers created 3D maps of proteins like β-amyloid and tau, which cause dementia.

Featured Neurology Neuroscience

·July 11, 2024·3 min read

Predicting Cognitive Decline in Early Alzheimer’s

A new study predicts cognitive decline rates in people with early Alzheimer's and explores how new drugs may slow this process. Researchers found that prediction models can estimate the rate of decline but with some uncertainty. These models could eventually help answer practical questions about quality of life for patients. The findings highlight the potential of new treatments to delay cognitive impairment.

Featured Neuroscience

·June 28, 2024·5 min read

Serotonin 2C Receptor Key to Memory

Researchers discovered the serotonin 2C receptor in the brain plays a crucial role in regulating memory in both humans and animal models. This breakthrough offers insights into conditions associated with memory loss, such as Alzheimer’s disease, and suggests new treatment pathways.

Featured Genetics Neurology Neuroscience

·June 28, 2024·4 min read

New Molecular Signatures Found for Alzheimer’s Disease

Researchers identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease. They discovered altered communication between brain vascular cells mediated by VEGFA and SMAD3 molecules. These findings could lead to new diagnostic biomarkers and treatment options for Alzheimer's.

Featured Neurology Neuroscience

·June 25, 2024·7 min read

AI Model Predicts Alzheimer’s Using Speech Analysis

can predict whether someone with mild cognitive impairment will develop Alzheimer's disease with 78.5% accuracy by analyzing speech. This tool could enable earlier diagnoses and more accessible cognitive impairment screening without expensive tests. The model uses machine learning to evaluate speech content, offering a non-invasive way to monitor dementia risk. Further research aims to improve and expand this technology.

This shows an older man and a brain scan.

Featured Neurology Neuroscience

·June 21, 2024·4 min read

Ozempic May Reduce Alzheimer’s Risk

GLP-1 agonists like Ozempic reduce the risk of dementia in type 2 diabetes patients. The research followed over 88,000 individuals for up to ten years, showing a 30% lower risk compared to sulfonylureas and a 23% lower risk compared to DPP-4 inhibitors. These findings can guide doctors in selecting medications for older diabetes patients. However, further randomized trials are needed to confirm these results.

Featured Neurology Neuroscience

·June 21, 2024·8 min read

Synthetic Peptide Reverses Alzheimer’s Symptoms

Researchers reversed Alzheimer's symptoms in mice using a synthetic peptide, PHDP5, that targets brain function. The study shows that PHDP5 can cross the blood-brain barrier and restore memory by improving synaptic function. The treatment could delay cognitive decline if administered early. This breakthrough paves the way for new Alzheimer's therapies focusing on brain structure and function.

Featured Genetics Neurology Neuroscience

·June 17, 2024·6 min read

Maternal Alzheimer’s: A Risk Factor for Brain Changes

A new study finds that inheriting Alzheimer's risk from your mother, regardless of her age at onset, is linked to increased amyloid levels in the brain. This protein is a hallmark of Alzheimer's disease. The findings suggest maternal history of memory impairment, even without a formal diagnosis, could be a crucial factor in identifying individuals at risk of Alzheimer's.

1 … 17 18 19 20 21 … 213

Alzheimer’s disease

Neural Vulnerabilities and Resilience in Alzheimer’s Explored

Anxiety Raises Dementia Risk

New Type of Age-Related Memory Loss Identified

AI Predicts Alzheimer’s Progression

Study Reveals Structure of Alzheimer’s Molecules in Human Brain

Predicting Cognitive Decline in Early Alzheimer’s

Serotonin 2C Receptor Key to Memory

New Molecular Signatures Found for Alzheimer’s Disease

AI Model Predicts Alzheimer’s Using Speech Analysis

Ozempic May Reduce Alzheimer’s Risk

Synthetic Peptide Reverses Alzheimer’s Symptoms

Maternal Alzheimer’s: A Risk Factor for Brain Changes

Primary Cilium Shapes the Developing Brain

The “Goldilocks” Choice: Why Older Adults are Turning to Cannabis

Why Regret Loses Its Sting as We Age

High Cognitive Scores Might Predict Depressive Relapse

Subscribe